Let’s start up with the current stock price of Ensysce Biosciences Inc. (ENSC), which is $0.69 to be very precise. The Stock rose vividly during the last session to $0.6149 after opening rate of $0.5785 while the lowest price it went was recorded $0.55 before closing at $0.61.Recently in News on March 6, 2023, Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar. ~ Ensysce Biosciences and Quotient Sciences Showcase a Unique Collaboration ~. You can read further details here
Ensysce Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $33.0000 on 04/06/22, with the lowest value was $0.4557 for the same time period, recorded on 02/28/23.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Ensysce Biosciences Inc. (ENSC) full year performance was -96.80%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ensysce Biosciences Inc. shares are logging -97.90% during the 52-week period from high price, and 51.82% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.46 and $33.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4692861 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Ensysce Biosciences Inc. (ENSC) recorded performance in the market was -7.75%, having the revenues showcasing -23.98% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 14.90M.
The Analysts eye on Ensysce Biosciences Inc. (ENSC)
During the last month, 0 analysts gave the Ensysce Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3896, with a change in the price was noted -3.13. In a similar fashion, Ensysce Biosciences Inc. posted a movement of -81.69% for the period of last 100 days, recording 2,008,883 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ENSC is recording 0.26 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.26.
Technical rundown of Ensysce Biosciences Inc. (ENSC)
Raw Stochastic average of Ensysce Biosciences Inc. in the period of last 50 days is set at 22.93%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 94.99%. In the last 20 days, the company’s Stochastic %K was 73.35% and its Stochastic %D was recorded 60.66%.
Considering, the past performance of Ensysce Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -7.75%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -90.39%, alongside a downfall of -96.80% for the period of the last 12 months. The shares 16.32% in the 7-day charts and went up by 13.42% in the period of the last 30 days. Common stock shares were lifted by -23.98% during last recorded quarter.
